Almaqdad Alsalloum
Baltiyskaya St. 8
Moscow, MOW 125315, Russian Federation
Moscow, MOW 125315, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Bayesian Population-Based Prevalence Estimation of KCNV2-Associated Retinopathy: A Comparative Analysis of Disease-Associated Variant Frequencies in Russian and Global Populations.
Journal: International journal of molecular sciences
Published: May 25, 2026
Culture of Human Retinal Explants as an Ex Vivo Model for Retinal Gene Therapy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 22, 2026
Electrophysiological Characterization of Photoreceptor-like Cells in Retinal Organoids Using Whole-Cell Patch Clamp Method.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 22, 2026
An AAV-Based Therapy Approach for Neurological Phenotypes of X-Linked Adrenoleukodystrophy.
Journal: International journal of molecular sciences
Published: October 12, 2025
Maturity-Onset Diabetes of the Young 10 (MODY10): A Comprehensive Review of Genetics, Clinical Features, and Therapeutic Advances.
Journal: International journal of molecular sciences
Published: July 18, 2025
Chromosomal Aberrations in Induced Pluripotent Stem Cells: Identification of Breakpoints in the Large DCC Gene and HIST2 Histone Gene Cluster.
Journal: International journal of molecular sciences
Published: June 20, 2025
A Comparative Analysis of Models for AAV-Mediated Gene Therapy for Inherited Retinal Diseases.
Journal: Cells
Published: September 12, 2024
Novel and Previously Known Mutations of the KCNV2 Gene Cause Various Variants of the Clinical Course of Cone Dystrophy with Supernormal Rod Response in Children.
Journal: Journal of clinical medicine
Published: July 15, 2024
Establishment of a human induced pluripotent stem cell line (ABi004-A) carrying a compound heterozygous mutation in the KCNV2 gene.
Journal: Stem cell research
Published: January 16, 2024
Generation of induced pluripotent stem cell line (MIPTi002-A) derived from a patient with a heterozygous type mutation in the CDC73 gene.
Journal: Stem cell research
Published: October 23, 2023
Last Updated: 09/26/2026